Inactive Instrument

News Arix Bioscience plc

Equities

ARIX

GB00BD045071

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

Merck Sharp & Dohme LLC completed the acquisition of Harpoon Therapeutics, Inc..	Mar. 10	CI
RTW Biotech Opportunities NAV increases 2.5% in January	Feb. 14	AN
RTW Biotech Opportunities Completes Arix Bioscience Acquisition	Feb. 13	MT
RTW Biotech Opportunities Ltd a fund managed by RTW Investments, LP completed the acquisition of Arix Biosciences Plc's assets from Arix Bioscience plc.	Feb. 12	CI
Katoro Gold launches fundraising, eyes board shake-up	Feb. 12	AN
Arix Bioscience's Asset Sale to RTW Biotech Takes Effect	Feb. 12	MT
Arix Bioscience shares suspended ahead of RTW takeover	Feb. 12	AN
Arix Bioscience Shares to be Suspended on London Exchange Amid Acquisition	Feb. 12	MT
Arix Bioscience Shareholders Approve Asset Sale to RTW Biotech	Jan. 29	MT
Arix Bioscience Gains UK Regulatory Approval for Sale to RTW Biotech	Jan. 23	MT
RTW Biotech completes Arix investment in takeover run-up	Jan. 22	AN
RTW Biotech Buys Minority Stake in Arix Bioscience to Support Planned Takeover	Jan. 22	MT
Arix Bioscience plc Announces Resignation of Directors	Jan. 22	CI
Arix Bioscience eyes USD19 million return from Harpoon sale	Jan. 19	AN
Arix Bioscience Flags Proceeds from Merck's Purchase of Harpoon Therapeutics	Jan. 19	MT
Rtw Biotech Opportunities Operating Ltd completed the acquisition of a 26.6% stake in Arix Bioscience plc from Acacia Research Corporation for £47.2 million.	Jan. 18	CI
Arix Bioscience's Portfolio Company Signs $680 Million Takeover Deal with Merck & Co.	Jan. 08	MT
Merck Sharp & Dohme LLC entered into an agreement to acquire Harpoon Therapeutics, Inc. for $410 million.	Jan. 07	CI
Arix Bioscience's Portfolio Company Doses First Patient in Late-stage Trial of Choroidal Melanoma Therapy	Dec. 08	MT
RTW Biotech Opportunities Ltd a fund managed by RTW Investments, LP agreed to acquire Arix Biosciences Plc's assets from Arix Bioscience plc for £190 million.	Nov. 30	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Arix Bioscience plc

Equities

ARIX

GB00BD045071

Summary

Filters